Volume | 659,533 |
|
|||||
News | (1) | ||||||
Day High | 0.198 | Low High |
|||||
Day Low | 0.18 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ReShape Lifesciences Inc | RSLS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.1904 | 0.18 | 0.198 | 0.1812 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
838 | 659,533 | $ 0.1900355 | $ 125,335 | - | 0.1414 - 4.10 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:29:31 | 300 | $ 0.180946 | USD |
ReShape Lifesciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.22M | 23.46M | - | 11.24M | -46.21M | -1.97 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ReShape Lifesciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RSLS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.1729 | 0.198 | 0.17 | 0.1832302 | 511,848 | 0.00805 | 4.65% |
1 Month | 0.1786 | 0.198 | 0.1456 | 0.1719317 | 474,911 | 0.00235 | 1.31% |
3 Months | 0.2527 | 0.2994 | 0.1414 | 0.2058703 | 839,770 | -0.07175 | -28.39% |
6 Months | 0.5541 | 0.60 | 0.1414 | 0.3165123 | 4,418,852 | -0.37315 | -67.34% |
1 Year | 2.98 | 4.10 | 0.1414 | 0.4005485 | 2,289,418 | -2.80 | -93.93% |
3 Years | 475.00 | 475.00 | 0.1414 | 76.49 | 1,537,900 | -474.82 | -99.96% |
5 Years | 475.00 | 475.00 | 0.1414 | 76.49 | 1,537,900 | -474.82 | -99.96% |
ReShape Lifesciences Description
Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. |